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Abstract: Magnetic beads (MBs) are versatile tools for the purification, detection, and quantitative
analysis of analytes from complex matrices. The superparamagnetic property of magnetic beads
qualifies them for various analytical applications. To provide specificity, MBs can be decorated with
ligands like aptamers, antibodies and peptides. In this context, aptamers are emerging as particular
promising ligands due to a number of advantages. Most importantly, the chemical synthesis of
aptamers enables straightforward and controlled chemical modification with linker molecules and
dyes. Moreover, aptamers facilitate novel sensing strategies based on their oligonucleotide nature that
cannot be realized with conventional peptide-based ligands. Due to these benefits, the combination
of aptamers and MBs was already used in various analytical applications which are summarized in
this article.
Keywords: aptamer; magnetic beads; analytical applications; electrochemical assays; optical assays;
point-of-care-testing
1. Introduction
Aptamers are synthetic single-stranded (ss) DNA (deoxyribonucleic acid) or RNA (ribonucleic
acid) molecules, which specifically bind to their target molecules with high affinity. They are selected
by an iterative in vitro process termed systematic evolution of ligands by exponential enrichment
(SELEX). In recent years, aptamers have been developed against a broad range of target molecules,
including metal ions, small molecules, peptides, proteins, and even complex targets such as whole
cells. Due to various advantages of aptamers, such as their animal free and cost effective production,
high temperature stability, chemical stability, target versatility, and high affinity and selectivity for their
targets, aptamers are appealing alternatives to antibodies (AB) for use in analytical applications [1].
The specific advantages offered by aptamers include the easy modification with functional groups
resulting in the possibility to control the orientation of the aptamer after immobilization. This controlled
orientation facilitates high activity of immobilized aptamers, which is beneficial in their analytical
applications [2]. In addition, aptamers can undergo considerable structural changes while interacting
with target molecules. These changes have been extensively studied and exploited for the development
of novel assays including target-induced structural switching (TISS) and target-induced dissociation
(TID) of complementary oligonucleotides (Figure 1). These possibilities are specific for aptamers
and allow for the design of sensing strategies even in cases, where conventional strategies, such as
sandwich assays are not applicable. Moreover, aptamers can be regenerated and aptamer-modified
sensors can be reused [3,4].
Recently, evolving analytical techniques and improved use of established methods have begun
to incorporate micro- or nano-sized magnetic beads (MBs) [5]. The specific properties of MBs,
such as colloidal stability of magnetic nanoparticles, homogenous size distribution, high and uniform
magnetite content, a fast response to applied magnetic field, and presence of surface functional groups
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are essential for their analytical applications. The superparamagnetic properties of MBs permit the
easy isolation of analytes from complex matrices, such as biological and environmental samples,
by attaching specific ligands on the surface of MBs and separating the MBs-bound analytes with the
aid of an external magnetic field. In order to provide different specificities, MBs can be functionalized
with various reactive groups, such as amines, carboxyls, epoxyls, and tosyls, which can be used to
immobilize high affinity ligands such as aptamers, proteins, antibodies, etc. according to required
applications [6]. Suspended modified MBs with immobilized ligands can be highly recommended
for the detection of analytes in complex matrices and the isolation of targets from larger volumes [7].
In some applications, the magnetic properties of the MBs, such as magnetic-relaxation switch,
have been used for signal generation [8,9]. Lately, magnetic separation processes have been introduced
in biotechnology for the purification of proteins [10–16], protein digestion [17–19], separation of
cells [20,21], and analytical applications [18,19,22–24].
Figure 1. (A) Target-induced structure switching (TISS) type of assay. Here, the interaction between an
aptamer and a target molecule leads to change in the conformation of the aptamer. The conformational
changes can be exploited for signal generation, e.g., by using an electroactive molecule (EA) fused to
the aptamer. In the figure, MGCE is a magnetic glass carbon electrode; (B) Target-induced dissociation
(TID) type of assay. Here, the aptamer is hybridized with a complementary oligonucleotide (cDNA).
The interaction between a target molecule and an aptamer leads to release of the cDNA sequence from
the aptamer. The release of the cDNA can provide different types of signals in different assay formats,
in the given example FRET-is used for signal generation. Adapted from [3] with permission. Copyright
2014, De Gruyter.
The combination of MBs with aptamers opens up new possibilities in a number of applications,
such as sample preparation, wastewater treatment, water purification, disease therapy, disease
diagnosis including magnetic resonance imaging, cell labelling and imaging, and biosensors. Within
this review article, first a brief introduction of magnetic beads and their applications will be given in
Section 2. In Section 3, the use of aptamer-modified MBs in biosensing will be described and recent
examples will be highlighted.
2. Magnetic Beads and Their Biological Applications
Within this section magnetic beads will first be briefly introduced together with potential strategies
to modify their surfaces. Consequently, the use of magnetic beads in some of the important biological
applications such as separating biomolecules from complex matrices will be described.
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2.1. Magnetic Beads and Their Modification
In 1792, William Fullarton described the separation of iron material with a magnet in a patent,
which paved the way for applications of magnetic fields in separation techniques [6]. Initially,
magnetic properties of sediments were used for separation. In 1852, a company from New York
separated magnetite from apatite and later on, magnetite was separated from iron from brass fillings,
turnings, metallic iron from furnace products and plain gauge etc. Gradually, magnetic separation
evolved into complex and diverse commercial applications. In 1950, introduction of high gradient
magnetic separation (HGMS) systems allowed faster and broad magnetic separation applications [25].
Towler et al. [26] reported the use of micron sized magnetite particles with adsorbent, manganese
dioxide, on the surface to recover radium, lead and polonium from seawater samples. Remarkably,
Safariková et al. introduced silanized magnetite particles (blue magnetite [27]) in magnetic solid-phase
extraction (MSPE) for the first time to preconcentrate organic compounds [28] prior to analysis.
Nowadays, magnetic separations have been widely used for protein purification [10–16], separation
and purification of cells [20,21], and analytical applications [18,19,22–24].
In recent applications, MBs are largely composed of a magnetic core, a surface coating, and specific
binding ligands at the surface (Figure 2). Generally, magnetic cores can be composed from various
materials, which exhibit magnetic properties. Largely, they consist of either pure metals (e.g., Co, Fe,
and Ni) or their oxides. In addition, transition-metal-doped oxides and metal alloys, including CoPt3,
FeCo, and FePt, are also good candidates. Among these magnetic materials, particularly iron oxides
such as magnetite (Fe3O4) and maghemite (γ-Fe2O3) are considered to be the most attractive candidates
for biological applications, owing to their strong magnetic property and biocompatibility [6]. U.S. Food
and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the use
of iron oxide MBs as magnetic resonance imaging (MRI) contrast agents [29]. Several approaches
are available to synthesize the iron oxides. One widely used approach is co-precipitation from iron
(III) chloride and iron (II) chloride solutions in the presence of aqueous ammonia solution [20,30,31].
Other methods are available including the extraction of bacterial magnetic particles (BMPs) from the
flagella of magnetic bacteria from marine sediments [32,33].
Figure 2. Composition of magnetic beads (MBs) used in analytical applications.
Finely divided iron is highly reactive toward oxidizing agents in the presence of water or humid
air. Thus, surface coating of magnetic particles is required to obtain physically and chemically stable
systems. Such stabilization can be achieved by surface coating of the magnetic particles in numerous
ways (Figure 2). Surface coating can be performed by using stabilising surface coating material,
encapsulation into polymeric shells and into lipososmes [34].
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Surface coating is primarily necessary to stabilize the newly formed surface of the particles and to
prevent aggregation of the particles. Surface stabilization is generally achieved using nonpolymeric
stabilizers based on organic monomers such as alkanesulphonic and alkanephosphonic acids,
or phosphonates; oleic acid, lactobionic acid, lauric acid, or polymeric stabilizers, i.e., alginate,
chitosan, dextran, polyethylene glycol, polyvinyl alcohol, pullulan, or polyethylene imine (Figure 2) [6].
Encapsulation into polymeric shells improves the water dispersibility and chemical and physical
stability of the magnetic particles. In addition, the polymeric shell can provide a basis for conjugation
of the magnetic particles to the targeting ligands by providing functional groups such as amine or
carboxyl groups on the surface. Several ligands are available for the analytical purpose; the most
popular among them are antibodies (ABs), aptamers, and peptides. The commonly used approach
to attach ABs to MBs is the coupling of amine groups of the AB to carboxylated MBs via ethyl
(dimethylaminopropyl) carbodiimide/N-hydroxysuccinimide (EDC/NHS) chemistry, but this can
lead to random orientation of AB on the MBs. Different strategies have been attempted to avoid
random orientation. For example, protein A can be used in order to immobilize the AB on the MB in a
controlled orientation [35].
Currently, aptamers are also becoming popular for analytical applications. Several strategies
are used for immobilising aptamers on the MBs. One of the popular strategies is to introduce amine
groups on one terminus of the aptamer to allow immobilization to carboxylated MBs via EDC/NHS
coupling. In contrast to AB immobilization, this results in highly oriented immobilization of aptamers,
since only the terminal amine group can participate in coupling procedure. It is also possible to use
streptavidin coated MBs and biotin-labelled aptamer for the attachment. Most important advantage
here is the orientation of the aptamer, which can be easily controlled, as aptamers are chemically
synthesized. During chemical synthesis, various modifications can be attached at defined positions
within the aptamer sequence.
2.2. Separation of Biomolecules Using Modified MBs
The separation of biomolecules such as whole cells, proteins and peptides, and mRNA from
complex matrices is very challenging. In this context, MBs modified with specific ligands allow to
isolate the target molecule using strong magnets. This MB-based sample pre-treatment also allows
to increase the concentration of target molecules in case of low concentration of the target molecules.
In addition, time-consuming sample pre-treatment procedures like centrifugation, filtration and
solid-phase extraction can be avoided [10]. In the following paragraphs, some exemplary applications
of MBs to separate the biomolecules will be briefly discussed.
2.2.1. Cell Separations
MB-based separation of cells from complex mixtures has become a popular tool and a valuable
alternative to fluorescence activated cell sorting. In this process, specific aptamers or antibodies are
anchored on the surface of magnetic particles. As example, Herr et al. immobilised an aptamer against
leukemia cells on MBs. In this work, it was possible to specifically recognize the cells from complex
mixtures including whole blood samples [36]. In a similar work by Zamay et al., MBs modified with
aptamer against lung adenocarcinoma cells were used to separate circulating tumor cells (CTC) from
human blood [37]. Interestingly, the applications of aptamer-modified MBs have been also integrated
with microfluidic device to isolate cancer cell subpopulations [38]. Magnetic cell sorting (MACS) is
used with antibodies since a long time [39]. The US FDA has also approved the Cellsearch® system as
in vitro diagnostic system for the detection of CTC in the clinic [40].
2.2.2. mRNA Isolation
The isolation of mRNA using MBs is based on A-T pairing. Short sequence of dT (normally dT(25))
can be covalently attached to MBs, which will hybridise to dA-tail of mRNA and the isolation of mRNA
can be possible within 15 min [41]. This technique eliminates the cumbersome steps used in traditional
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methods of mRNA isolation such as use of centrifugation and membrane-based spin columns.
Importantly, MB-based isolation of mRNA fulfils the demand of automated systems and microfluidic
devices, thereby promoting fast processing and high sample throughput [42]. The possibility of
high throughput analysis has facilitated the identification of genetic aberrations in cancer cells [43],
understanding of biochemical pathways [44] and phylogenetic studies [45].
2.2.3. Protein and Peptide Enrichment
Traditionally, proteins are purified using expensive liquid chromatography systems, centrifuges,
filters and other equipment. In addition, this purification process requires several steps and there is
significant loss of protein/peptide at each step of purification. Purification using MBs reduces the
amount of handling step and all the step can be done in a single test tube, which results in higher
efficiency and reduced risk of contamination [46]. In some cases where intracellular proteins are
targeted, it is even possible to combine the disruption of cells and separation of the protein form the
complex mixture and thus shorten the total purification time. For example, Ni2+ or Co2+ coated MBs
can be used to easily purify His-tagged proteins from cells [6]. Alternatively, aptamer-modified MBs
can be used for the isolation of His-tagged proteins [47] or other proteins [48].
These methods can be used to isolate and enrich proteins prior to analysis. For example,
immunomagnetic assays rely on MBs modified with antibodies (AB). Enzyme-linked immunosorbent
assay (ELISA) is a gold-standard method for the detection of the protein in complex mixture.
In immunomagnetic assays, the capturing antibody is immobilized on the MBs, which can reduce the
incubation time and efficiency of the assay, as MBs remain suspended throughout the procedure [49].
Morozov et al. have developed an immunomagnetic assay for the detection of streptavidin in a
micorofluidic device. This has been highly successful in reducing the assay time (three minutes)
and better sensitivity (2 × 10−17 M) of the assay [50]. While Section 2 provided a brief overview on
the general biological applications of magnetic beads, the next section will focus on the analytical
applications of aptamer-modified magnetic beads.
3. Aptamer-Modified Magnetic Beads in Analytical Applications
In aptamer-modified MB-based assays, aptamers are used as binding ligands and MBs are
mostly used for the separation of the analyte from complex matrices. MBs have also been coupled
with antibodies, but aptamer-based assays offer prominent advantages such as high stability, broad
dynamic range, prolonged shelf life, and low cross reactivity [51]. Moreover, aptamers are synthesized
chemically, which facilitates straightforward and highly controlled modification with functional groups
and different labels [52]. Moreover, the use of aptamers facilitates new assay designs that cannot
be realized by using Abs. Aptamers can undergo significant conformational change upon binding
to the target molecule. This can be exploited in target-induced structure switching (TISS)-based
assays. Another assay format specific for aptamers is based on target-induced dissociation (TID) of
complementary oligonucleotides. In case of TID, aptamers ability to hybridize with complementary
sequences are used. Here, the helix structure formed between aptamer and its complementary sequence
can be easily dissociated by competitive binding of the aptamer with its target (Figure 1). TISS as well
as TID can be used for signal generation in various sensing strategies and are especially useful in cases
were conventional formats such as sandwich assays are not applicable [3,53,54].
As shown in Table 1, a growing number of research groups are already using aptamer-modified
MBs in analytical applications using various sensor designs. In the following sections, the applications
have been broadly divided in the electrochemical, optical, piezoelectric and PCR-based assays.
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Table 1. Examples of coupling magnetic beads in aptamer-based analytical applications.
Method Analytes Detection Limit Reference
Electrochemical
Voltammetric
Differential pulse voltammetry (DPV) Human activated protein C 2.35 µg mL−1 [55]
DPV Thrombin 5.5 fM [56]
DPV Thrombin 5 nM [57]
DPV Human liver hepatocellular carcinomacells (HepG2) 15 cells mL
−1 [58]
DPV Platelet derived growth factor BB(PDGF BB) 0.22 fM [59]
DPV Adenosine 0.05 nM [60]
DPV Hg2+ 0.33 nM [61]
Squarewave voltammetry (SWV) Tumor necrosis factor-alpha (TNF-α) 10 pg mL−1 [62]
SWV Ochratoxin A 0.07 pg mL−1 [63]
Potentiometric
Potentiometric carbon-nanotube aptasensor Variable surface glycoprotein fromAfrican Trypanosomes 10 pM [64]
Direct Potential Measurement Listeria monocytogenes 10 cfu mL−1 [65]
Chronopotentiometry Vibrio alginolyticus 10 cfu mL−1 [66]
Impedimetric
Electrochemical impedance spectroscopy Salmonella 25 cfu mL−1 [67]
Impedimetric microfluidic analysis Protein Cry1Ab 0.015 nM [68]
Microfluidic impedance device Thrombin 0.01 nM [69]
Electrogenerated Chemiluminescence
Electrochemiluminescence resonance energy
transfer system β-amyloid 4.2 × 10
−6 ng mL−1 [70]
Ratiometric electrochemiluminescence Cancer cells 150 cells mL−1 [71]
Optical
Fluorescence
Signal-on fluorescent aptasensor Ochratoxin A 20 pg mL−1 [72]
Aptamer-conjugated upconversion nanoprobes assisted
by magnetic separation Circulating tumour cells 20 cells mL
−1 [73]
Enzyme-linked aptamer assay Oxytetracycline 0.88 ng mL−1 [74]
Colorimetric
Colorimetric assay (Methylene Blue-based) Hg(II) 0.7 nM [75]
Chemiluminescence
Chemiluminescent Hepatitis B Virus 0.1 ng mL−1 [76]
Chemiluminescence (integrated microfluidic system) Glycated haemoglobin
0.65 g dL−1 for
HbA1c and
8.8 g dL−1 for Hb
[77]
Surface enhanced Raman scattering
Molecular embedded SERS aptasensor Aflatoxin B1 0.0036 ng mL−1 [78]
Universal SERS aptasensor Aflatoxin B1 0.54 pg mL−1 [79]
Induced Target-Bridged Strategy platelet derived growth factor BB 3.2 pg mL−1 [80]
Piezoelectric
Quartz crystal microbalance sensor Salmonella enterica 100 cfu mL−1 [81]
Magnet-quartz crystal microbalance system Acute leukemia cells 8 × 103 cells mL−1 [82]
PCR-based assays
Apta-qPCR ATP 17 nM [54]
Apta-qPCR Ochratoxin A 0.009 ng mL−1 [53]
Rolling circle amplification Cocaine 0.48 nM [83]
Micromagnetic aptamer PCR PDGF-BB 62 fM [84]
Real-time PCR Escherichia coli 100 cfu mL−1 [85]
Magnetic relaxation
Magnetic nanosensors CCRF-CEM cell 40 cells mL−1 [8]
Magnetic relaxation switch Pseudomonas aeruginosa 50 cfu mL−1 [9]
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3.1. Electrochemical
Since the first use of electrochemical (EC) assay for the detection of glucose by Clark and Lyons in
1963 [86], the applications have evolved in different kind of assays including ABs and aptamer-based
assays. EC assays are generally rapid, highly sensitive, cost-effective and easy to miniaturize, which is
highly attractive for the development of modern bioassays. In aptamer-based electrochemical assays,
the change in electrochemical signals (current, voltage, and impedance) due to interaction of analytes
and aptamers is measured [87].
EC assays can be broadly classified as amperometric, potentiometric, voltammetric, impedimetric,
and electrogenerated chemiluminescence (ECL) assays, according to their working principles.
In Table 1, recent work on aptamer-modified MBs in different electrochemical assays is summarized.
3.1.1. Voltammetric Assays
In voltammetric assays, a specific potential is applied to a working electrode in comparison
to a reference electrode. The electrochemical reduction or oxidation at the surface of the working
electrode results in the generation of a current. Here, amperometric assays are included as a subclass
of voltammetric assays as, in amperometric assays also, a constant potential is applied on the working
and reference electrode, and the change in current is measured over a period of time. In case of
voltammetric assays, a potential range is applied and the changes in both, current and potential are
observed. In both assays, the observed change in current is proportional to the concentration of the
analyte. Different voltammetric modes are available such as cyclic voltammetry (CV), differential pulse
voltammetry (DPV), squarewave voltammetry (SWV), and alternating current voltammetry (ACV) [88].
CV is majorly used to evaluate the electrode surface including purity, stability, and reproducibility of
the electrode and to examine the aptamer immobilization on the electrode surface since it allows to
check the redox behaviour over a wide potential range [58,88,89].
3.1.2. Differential Pulse Voltammetry (DPV)
Due to its sensitivity and high selectivity, DPV is preferred in analytical applications. In DPV,
different electroactive labels are used to generate the signal including small molecules and enzymes,
such as horseradish peroxidase (HRP), alkaline phosphatise (AP), and glucose oxidase (GOD), etc.
Among these enzyme labels, HRP is one of the most commonly used. For example, Zhao et al. [56]
developed a highly sensitive and selective assay for the detection of thrombin (Figure 3A). In this
assay, the capture probe was prepared to capture thrombin from the sample solution by immobilizing
a thrombin aptamer-1 on MB-AuNP. The detection probe was prepared from another thrombin
aptamer-2, horseradish peroxidase (HRP), thiolated chitosan (CS) nanoparticle and gold nanoparticle
(CS-AuNP-HRP-Apt2). Presence of thrombin resulted in formation of the sandwich structure of
MB-AuNP-Apt1/thrombin/Apt2-HRP-AuNP-CS. The sandwich structures were captured on the
surface of a screen printed carbon electrode (SPCE) by a magnet located at the edge of SPCE. Due to the
presence of HRP within the sandwich structure, the oxidation of hydroquinone (HQ) with H2O2 was
dramatically accelerated. The observed electrochemical signal was proportional to the concentration
of thrombin in the samples. A similar assay was also developed by Sun et al. [58] for the detection of
human liver hepatocellular carcinoma cells (HepG2).
Centi et al. [57] have developed an electrochemical sandwich assay coupled to magnetic beads
for the detection of thrombin in plasma. In this work, a microfluidic device was developed for the
detection. The electrodes were screen-printed on a magnetic bar. Two different aptamers against
thrombin were used where the first aptamer sequence was immobilised on MBs, to capture thrombin
from the samples, using streptavidin-biotin interactions. The second aptamer was linked to alkaline
phosphatase. The presence of thrombin in the sample resulted in current generation at the electrode,
as more product was formed in the presence of alkaline phosphatase.
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Zheng et al. [59] have developed an assay based on aptamer-conjugated to methylene blue for
the detection of human platelet-derived growth factor BB (PDGF-BB). In this work, boronic acid
modified SiO2@Fe3O4@PDA@AuNP composite was used to capture PDGF-BB from the sample.
An aptamer against PDGF was linked to SiO2-methylene blue sphere, where methylene blue
was used for its high electron-transfer efficiency. Due to the magnetic property of the electrode,
the SiO2@Fe3O4@PDA@AuNP/PDGF/aptamer-SiO2-methylene blue could be easily enriched on the
electrode surface. Later on, the electrochemical responses could be detected to quantify PDGF.
Figure 3. Utilization of MBs in aptamer-based electrochemical assays. (A) Using an electric signal
mediator. Here, the electroactive molecules (HRP) were brought close to the electrode using
aptamer-modified MBs. Reproduced with permission from [56]. Copyright 2012, Royal Society of
Chemistry; (B) Signal-on type of electrochemical assay. The interactions between aptamers and
the target molecules (Chloramphenicol and PCB 72) lead to generation of electrochemical signal.
Reproduced with permission [90]. Copyright 2015, Elsevier; (C) Signal off type of electrochemical assay.
In this type of assay, the interaction between the aptamer and the target molecule leads to reduction in
electric signal. Reproduced with permission from [62]. Copyright 2017, Springer.
While in the previous examples, proteins were detected with aptamer-modified MBs, also small
molecules are suitable targets, which can be detected e.g., by using the aptamer-specific TISS and
TID-based assays. In this context, a TID-based label-free assay was developed by Yang et al. [60] for
the detection of adenosine using thionine (Th) for generation of the electrochemical signal. In this
work, adenosine aptamer was immobilised on MBs and an oligonucleotide complementary to the
target-binding site of the aptamer (abbreviated as cDNA) was hybridized to the immobilized aptamer.
Addition of adenosine resulted in the formation of aptamer-adenosine complex and the release of
cDNA from the aptamer due to TID. The released cDNA was captured on the sensing electrode through
DNA hybridization. As the cDNA is modified with thiol groups at the 5′ termini, AuNP can attach to
the cDNA via the formation of S-Au bonding. Subsequently, the electroactive molecules, thionine, are
adsorbed on the surfaces of the AuNPs and result in signal generation.
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A TISS-based assay in which the structural changes of the aptamer were exploited for signal
generation was developed by Wu et al. [61] for the detection of Hg2+ using streptavidin modified
magnetic beads (Fe3O4-SA) and thionine, as electron mediator. In this work, Streptavidin-modified
MBs (MB-SA) were immobilized onto the glassy carbon electrode (GCE) and provided magnetic
character to the electrode. Then biotin-labelled aptamer against Hg2+ was immobilized to the electrode
via SA-biotin interaction. Addition of Hg2+ resulted in a stable folded structure of thymine (T)-Hg2+-T
where Th can easily intercalate. The detection of Hg2+ was achieved by recording the DPV signal of Th.
3.1.3. Squarewave Voltammetry (SWV)
SWV is the popular pulse technique and widely considered for automatous and kinetic studies
complementary to cyclic voltammetry. Here, TID-based assays are very popular and the interaction of
the aptamer with the target molecule can result in electrical signal gain (signal-on) or signal suppression
(signal-off).
Yan et al. [90] have developed an assay for the simultaneous detection of two different molecules,
chloramphenicol and polychlorinated biphenyls-72 using a signal-on mechanism (Figure 3B). In this
work, aptamers were immobilised on MBs and hybridised with a cDNA sequences attached to CdS
or PbS QDs as electrochemical signal tracers. Binding of chloramphenicol caused the release of CdS
QDs and binding of polychlorinated biphenyls-72 caused the release of PbS QDs. The released CdS
and PbS QDs were simultaneously detected through the square wave voltammetry (SWV), which can
switch the signals of the biosensor to “on” state. Hao et al. [63] have also developed an assay based on
signal-on approach for the detection of ochratoxin A (OTA). In this work, addition of OTA caused the
release of CdTe QDs modified with cDNA, from the MB-modified aptamers. After magnetic separation
of aptamer-modified MBs, CdTe QDs remaining in the supernatant were dissolved by HNO3 and the
concentration of Cd ions, which was directly proportional to the concentration of OTA, was detected
by SWV.
Miao et al. [62] have developed a signal-off assay for the detection of TNF-α (Figure 3C). In this
simple assay, methylene blue-tagged aptamer was immobilised on magnetic glassy carbon electrode
(MGCE) using a cDNA. Addition of the target molecule resulted in release of methylene blue-tagged
aptamer, resulting in decrease in electrochemical signal by SWV.
3.1.4. Potentiometric Assays
In potentiometric sensors, the change in electric potential between two electrodes is detected by
a field-effect transistor (FET) [91]. Here, the indicator electrode reports change in electric potential
according to analyte concentration and the reference electrode provides constant electric potential.
Recently, Zhao et al. [66] have developed a potentiometric sensor for the detection of
Vibrio alginolyticus, which is an opportunistic marine pathogen and can cause otitis, wound infection,
and chronic diarrhoea in mammals. In this work, a cDNA sequences were immobilized on the surface
of the magnetic beads using streptavidin-biotin interaction. The aptamer and H1/H2 (two different
oligonucleotides) hybridize successively with the cDNA to form the DNA structure-modified magnetic
beads. The resulted DNA structure can interact with protamine (polycation) due to electrostatic
interactions, which can be detected by the polycation-sensitive electrode. When a sample containing
Vibrio alginolyticus was added, the aptamers interact with the target due to its high affinity with the
target. Consequently, the DNA structure disassembled and a reduction in potential was observed
which was proportional the target concentration. A similar assay was also used for the detection of
small molecules such as bisphenol A [92].
3.1.5. Impedimetric Assays (EIS)
In impedimetric assays, electrochemical impedance spectroscopy (EIS) is popular due to its high
sensitivity. EIS involves the analysis of the resistive and capacitive properties, which are based on the
perturbation of a system at equilibrium by a small amplitude of excitation signal. EIS allows rapid and
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accurate detection of the small changes along the electrode by a transducer. The signal is enhanced
by an amplifier, which makes EIS appealing in analytical applications. In addition, EIS is a simple
technique and the detection in EIS does not require attachment of capture molecules to the electrodes
and thus allows label-free detection.
Wang et al. [69] have developed a microfluidic analysis system assay for the detection of thrombin
using aptamer-modified magnetic separation. In this work, thrombin aptamer-modified MBs were
used to capture and separate the target protein from serum. Later on, the bound complex was injected
into the microfluidic flow cell for impedance measurement. Similar analysis system was also developed
by Jin et al. [68] for the detection of Cry1Ab protein to detect genetically modified crops. Another
interesting impedimetric assay based on TID mechanism was developed by Lee et al. [93] for the
detection of prostate-specific antigen (PSA). Combining PSA aptamer-modified magnetic nanoparticles
with rolling circle amplification (RCA) has provided a better sensitivity of 0.74 pg mL−1 PSA in
human serum.
3.1.6. Electrogenerated Chemiluminescence
Electrogenerated chemiluminescence (ECL), also called electrochemiluminescence, refers to
the emission of light via electron transfer reactions from electrochemically generated reagents.
ECL combines the sensitivity and wide dynamic range from chemiluminescence (CL) with the
advantages offered by electrochemical methods, such as simplicity, stability, and facility to be
miniaturized [94,95]. Lately, ECL has been widely accepted in different analytical applications including
fundamental studies to detecting trace amount of target molecules. Among different luminophores,
use of luminol, quantum dots (QDs) and ruthenium(II) complexes, have been widely employed in
ECL assays [96].
Ke et al. [70] have developed an assay for the detection of β-amyloid (Aβ) using a sandwich-type
ECL sensing platform. In this work, Ru(bpy)32+ was used as ECL donor and gold nanorods (GNRs)
were used as ECL acceptor. Here, resonance energy transfer (RET) donor nanohybrids were prepared
with mesoporous carbon nanospheres (MCNs)@nafion/Ru(bpy)32+/Aβ antibody. After incubation
with target Aβ protein and GNRs-attached aptamer, prominent decrease in ECL signal was observed
due to the quenching effect between Ru(bpy)32+ and GNRs. This innovative approach performed well
with sensitivity of 4.2 fg mL−1 in real Alzheimer’s patient cerebrospinal fluid samples.
In a TID-based approach, Wang et al. [71] have developed a novel ECL sensing system for the
detection of HL-60 cancer cells. Here, Ag-polyamidoamine (PAMAM) was prepared and functionalized
with cDNA and bio-bar-code DNA (bbcDNA). The prepared composite was hybridized with the
aptamer-modified MBs. Addition of HL-60 cancer cells resulted in the release of cDNA-Ag-PAMAM
composite in the supernatant. For the detection, an oligonucleotide complementary to cDNA was
immobilised on the electrode surface resulting in hybridization of released cDNA-Ag-PAMAM.
3.2. Optical
Optical assays have been widely used due to their specific advantages such as high sensitivity,
quick response, high signal-to-noise ratio, reduced cost of manufacture, and relatively simple operation.
Aptamers are preferred ligands in optical assays due to flexibility in modification with various
fluorophores and other labels. As already described for electrochemical assays, application of
aptamer-modified MBs can be highly advantageous due to easy separation of the target molecule from
the complex matrices, which offers high signal-to-noise ratio during measurement. The assays can be
classified based on the detection principle including fluorescence, colorimetry, chemiluminescence,
surface plasmon resonance (SPR), and Raman scattering.
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3.2.1. Fluorescence Based Assays
Aptamer-based fluorescence assays can be mainly divided into labelled and label-free assays.
Easy modification of aptamers with fluorophores and quenchers during chemical synthesis facilitates
the design of various assays.
Luo et al. [97] developed a nicking enzyme assisted signal amplification (NEASA)-based assay
relying on TID mechanism (Figure 4A). In their work, ampicillin aptamer was immobilised on MBs
and attached to a complementary sequence (cDNA) through Watson-Crick base pairing. Addition
of ampicillin resulted in release of cDNA which can bind to Taqman probe having fluorescent and
quencher probes at opposite end. The nicking enzyme cleaved the Taqman probe only when it was
bound to cDNA. The decrease in fluorescence signal was proportional to the concentration of ampicillin.
Figure 4. Fluorescence-based assays. (A) Combining fluorophores and quencher molecules. Here the
interaction between the aptamer and the target molecule leads to the release of quencher molecule and
the increase of fluorescence signal. Reproduced with permission from [97]. Copyright 2017, Elsevier;
(B) Label-free assay. Being oligonucleotides, aptamers can specifically interact with dyes specific for
ssDNA or dsDNA. In this example, Tb3+ was used which interacts specifically with ssDNA (cDNA),
which was released due to TID from ochratoxin A (OTA) aptamer. Reproduced with permission
from [72]. Copyright 2013, Elsevier.
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Upconversion nanoparticles (UCNPs), nanocrystals containing lanthanide ions, emerged as an
important fluorophor, as they lack autofluorescence and their use result in high signal-to-noise ratio.
In addition, the optical properties of UCNP can be tuned with different lanthanide dopants such as Er3+,
Tm3+, and Ho3+ [98,99]. Fang et al. [73] developed an assay for the detection of circulating tumor cells
(CTC) using UCNPs. In their work, UCNPs were modified with the aptamer and biotinylated-PEG.
Aptamer was used to recognize CTC and biotinylated-PEG was used to attach UCNP to the MBs.
Here, whole blood samples were mixed with the modified UCNPs and it was possible to detect as
low as 10 cells into 0.5 mL of whole blood samples. Efforts have been also made to further increase
the sensitivity of fluorescence-based assays. In this context, Wang et al. [100] used RuBpy-doped
silica nanoparticles (RSiNPs), which are highly photostable and provide significant enhancement in
fluorescent signal when compared with single RuBpy dye molecules. In this work, aptamer-modified
MBs were used to separate thrombin from human serum.
Aptamer-modified MBs have been also used in enzyme-linked aptamer sandwich assays.
John Bruno et al. [101] used aptamer-modified MBs to capture Campylobacter jejuni from the samples.
Later on, a second aptamer modified with QDs was introduced. The bound complex was brought
on the photo detector using external magnet. The whole detection procedure could be finished in
15 min and resulted in high sensitivity. Similar detection principle was also used by Hao et al. for the
detection of thrombin [102].
To reduce the labelling cost and reducing the effect of labelling on aptamer conformation, label free
assays have attracted big attention. Being DNA sequences, aptamers can also bind to DNA binding
chemicals, such as crystal violet [103], SYBR Green I (SGI) [104,105], 4′,6-diamidino-2-phenylindol
(DAPI) [106], malachite green [107], OliGreen [108] and terbium (III) (Tb3+). Zhang et al. [72] developed
a label-free fluorescent aptasensor based on the Tb3+, structure-switching of anti-OTA aptamer and
MBs for the detection of ochratoxin A in wheat (Figure 4B).
3.2.2. Colorimetric Assay
Colorimetric assays are widely used in analytical application due to simplicity of the measurement.
Among aptamer-based colorimetric assays, AuNP-based assays are widely used. MBs-based separation
in these assays provide better signal-to-noise ratio and sensitivity.
For example, Liang et al. [109] reported an aptamer-protein interaction-induced aggregation assay
for the detection of thrombin. In their work, two different aptamers against human α-thrombin were
immobilised on nanoroses (MB-AuNP core-shell structure in a flowerlike shape). Addition of human
α-thrombin in solution resulted in aggregation of nanoroses and thus in a characteristic change in
UV-Vis absorption spectra of the colloid. An interesting assay was also developed by Wang et al. [75]
for the detection of Hg(II) based on hybridization chain reaction (HCR). In this work, aptamer against
Hg(II) were immobilized on the MB-AuNP. HCR process is inhibited in the presence of Hg(II) enabling
less methylene blue to intercalate into the dsDNA structure.
The use of peroxidase-like activity of magnetic nanoparticles is exploited in different colorimetric
assays. Kim et al. [110] reported an assay for the detection of metal ions. Here, the aptamers were
adsorbed on the positively charged surface of MBs, which reduces the catalytic activity of MBs.
Addition of the target molecules released the adsorbed aptamers from MBs surface and MBs recover
the peroxidase-like activity. Similar assays were also developed for the detection of ochratoxin A in
cereal samples [111] and thrombin in blood plasma [112].
3.2.3. Chemiluminescence Assays
In chemiluminescence (CL) assays, the light emitted during a chemical reaction is detected.
The unique characteristics of CL include high sensitivity, wide dynamic ranges and simple
instrumentation. In case of CL, an excitation light-source is not required which is highly cost effective.
A label-free CL detection of adenosine in human serum was realized by Yan et al. [113]. In their
work, 3,4,5-trimethoxyl-phenylglyoxal (TMPG) was used as the signalling molecule for CL, as TMPG
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can intercalate with guanine (G) nucleobases. Firstly, the cDNA was immobilized on the surface of
MBs and hybridized with a G-rich adenosine aptamer. Addition of adenosine containing sample
caused the release of the aptamer from MBs modified with cDNA and a decrease in CL signal was
observed, which was proportional to adenosine concentration.
In contrast, HRP-based catalysis can be widely used for the generation of CL signal. As an
example for CL assays using HRP, Li et al. [114] immobilized aptamers directed against cocaine on
the surface of AuNP-functionalized MBs (MB-AuNP). Therefore, aptamers were hybridized with the
cDNA immobilized on the double-functional AuNP modified with HRP (HRP-AuNP). When cocaine
was introduced, a dissociation of the aptamer was achieved due to binding of the aptamer to cocaine.
Consequently, HRP-AuNP were eluted from the MB-AuNP due to target-induced dissociation (TID).
The recorded CL signals were proportional to the concentration of cocaine (Figure 5).
Figure 5. Chemiluminescence assay. This assay is based on TID. Here, the interaction between the
aptamer and the target molecule (cocaine) caused the release of cDNA attached to HRP-modified
AuNPs. Released HRP generated chemiluminescence signal which was proportional to cocaine
concentration. Reproduced with permission from [114]. Copyright 2011, Springer.
3.2.4. Surface-Enhanced Raman Scattering-Based Assays
Surface-enhanced Raman scattering (SERS) relies on the principle that the Raman scattering
intensity of molecules will be greatly improved after their adsorbtion onto the metal surface.
Quansheng et al. [78] developed a SERS assay for ultrasensitive detection of aflatoxin B1 (AFB1)
detection in peanut oil (Figure 6). In this study, AFB1 aptamers were immobilised on the MBs and
cDNA was immobilised on gold nanorods (cDNA-AuNRs). Presence of AFB1 resulted in the release of
cDNA-AuNRs and decrease in SERS signal was observed. In an interesting work, aptamer-conjugated
magnetic beads were used for the separation of circulating tumor cells from whole blood samples and
the tumor cells were detected using surface-enhanced Raman scattering imaging [115].
Yoon et al. [116] developed SERS-based magnetic aptasensors for the detection of thrombin in
serum samples. In this work, two different aptamers against thrombin were used for the detection.
One aptamer was immobilised on MBs and second aptamer was immobilised on AuNP-coated with
Raman reporter molecules, X-rhodamine-5-(and -6)-isothiocyanate (XRITC). Addition of thrombin
resulted in the formation of sandwich aptamer complexes and an increase of SERS signal according to
thrombin concentration in the sample was observed.
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3.3. Piezoelectric Assays
Since the discovery of piezoelectric effect in 1880 by the Curie brothers, the piezoelectric
effect has been very popular in analytical applications. Lately, the progress made in the fields of
microelectronics and microfluidics further promotes the development of label-free piezoelectric
assays [117]. Particularly, quartz-crystal microbalance (QCM)-based assays have become popular
in analytical applications of aptamers. Utilizing MBs in these assays is highly advantageous due to
their inherent piezoelectric properties, and potential to concentrate the analyte molecules at the QCM
surface [118].
Ozalp et al. [81] developed a QCM biosensor for the detection of Salmonella cells in food samples.
Here, aptamer-modified MBs were, firstly, used to capture the target pathogens from the food samples.
The magnetically separated pathogens were detected by QCM sensor and 100 cfu mL−1 Salmonella
cells could be detected in milk samples. In a similar assay, Pan et al. [82] detected leukemia cells in
complex matrices. In this work, aptamer-modified MBs were used to capture leukemia cells from the
biological sample and to approximate them to the QCM sensor using an external magnet.
Figure 6. Surface-enhanced Raman scattering-based assays. (A) Immobilization of aflatoxin B1
(AFB1) aptamer on gold nanorods (AuNRs). (B) Immobilization of cDNA on chitosan-modified MBs.
(C) Schematic representation of AFB1 measurement. Here, the binding of AFB1 induced the release of
cDNA and, in turn, AuNRs from the MBs and a decrease in SERS signal was observed. Reproduced
with permission from [78]. Copyright 2018, Elsevier.
An interesting approach was used by Song et al. [119] for the detection of ATP via
DNAzyme-activated and aptamer-based target-triggered circular amplification. In this work, AuNPs
were used for mass amplification and captured on the modified gold electrode. The amplification
scheme involved circular nucleic acid strand-displacement polymerization, aptamer binding strategy
and DNAzyme signal amplification. Presence of ATP resulted in a two-cycle amplification process,
triggered by the aptamer recognition of a target molecule.
3.4. PCR-Based Assays
Being oligonucleotide sequences, aptamers can be easily amplified and quantified using qPCR
with high sensitivity and reproducibility. Recently, different assays based on this property of aptamers
have been developed including Apta-qPCR, micromagnetic aptamer PCR (MAP), and assays involving
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PCR-based amplification strategies as loop-mediated isothermal amplification (LAMP), rolling circle
amplification, and isothermal signal amplification, proximity ligation assays, and nuclease protection
assays. In these assays, MBs provides opportunity to separate target-bound and unbound aptamers,
which is very important to get minimum background and high signal-to-noise ratios and in turn high
sensitivity and reproducibility.
Our group [53] developed an Apta-qPCR assay for the detection of ochratoxin A in beer samples
(Figure 7). In this work, ochratoxin A aptamer was hybridized to a corresponding cDNA, which was
immobilized on MBs. Addition of the target molecules caused TID of aptamer from the MBs and the
released aptamers were quantified using qPCR. This assay was able to detect 0.009 ng mL−1 OTA in
beer samples. Similar assay was also used for the quantification of ATP present in HeLa cell lysate
with the sensitivity of 17 nM ATP [54].
Figure 7. Apta-qPCR. This assay is based on TID, where the interaction of the target molecules
(ochratoxin A) caused the release of aptamer from the cDNA-modified MBs. The released aptamers
were quantified using qPCR. Reproduced with permission from [53]. Copyright 2017, Wiley.
Csordas et al. [84] developed an interesting concept for the detection of PDGF-BB using
combination of antibody and aptamer in MAP. In this work, high-gradient magnetic field sample
preparation was integrated within a microfluidic device with aptamer-based real-time PCR readout.
Antibody-modified MBs were used for capturing PDGF-BB and an aptamer against PDGF-BB,
which was modified with flanking PCR primer sequences, was added after washing. The bound
aptamers were quantified using qPCR.
Ozalp et al. [85] developed a qPCR-based assay where aptamer-modified MBs were used to
preconcentrate the Escherichia coli or Salmonella typhimurium. Later on, bacterial genomes were extracted
which was quantified using qPCR. A similar assay was also developed by Feng et al. [120] for the
detection of Listeria monocytogenes using a LAMP assay.
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4. Conclusions and Future Trends
Aptamers are attractive bioreceptors in analytical applications due to their small size, animal
free- and cost effective production, high stability (especially DNA aptamers), target versatility,
high binding affinity and selectivity for their target molecules. In addition, several properties of
aptamers including ease of chemical modification, measurable structural changes induced upon
interaction of the aptamer with the target molecule, and the potential to amplify aptamers via PCR are
advantageous in comparison to other binding ligands such as ABs. Due to these significant advantages
of aptamers, they have been widely used for the detection of different analytes ranging from metal
ions, small molecules, proteins to whole cells in diverse assay formats. In this review article, the
focus was put on the magnetic bead-based analytical applications of aptamers. Utilization of MBs
in aptamer-based applications allows to rapidly detect the analyte in the complex matrices with
high signal-to-noise ratio. Recent developments in the synthesis of MBs resulted in MBs with better
homogenous size distribution, high and uniform magnetite content, and a fast response to applied
magnetic field, as well as high colloidal stability of magnetic nanoparticles.
In this review, different assay formats have been discussed where MBs were coupled with
aptamers for the analytical applications. In many of the applications, MBs help to separate the target
molecule from complex matrices. In some applications the aptamer-modified beads are also enriched
directly on the sensor surface, thereby representing a surface modification used to immobilize the
target. In few applications, magnetic properties of the MBs, such as magnetic-relaxation switch,
have been used for signal generation.
Application of aptamer in analytical techniques is still in development phase, as many commercial
applications use ABs. Slowly but steadily, aptamers are developed against a range of molecules.
For some of them the development of other ligands, such as antibodies, is not easy, e.g., due to low
immunogenicity or high toxicity. Moreover, aptamers seem to be especially advantageous for the
detection of small molecules. In this context, TISS and TID mechanism provide the possibility to design
assays that can detect small molecules, while other strategies like sandwich assays are not suitable
for detection of small molecules. These advantages of aptamers and their combination with those of
MBs, can further boost the development of new analytical procedures. The use of MBs in these assays
can result in rapid detection of the target molecules even within complex matrices with no need for
time-consuming sample pre-treatment procedures. Taking together the strengths of aptamers and MBs
can therefore be especially advantageous in the development of POCT, where complex samples have
to be analyzed within minutes.
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